Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates

Pancreatic cancer (PC) is one of the deadliest malignancies worldwide, since patients rarely display symptoms until an advanced and unresectable stage of the disease. Current chemotherapy options are unsatisfactory and there is an urgent need for more effective and less toxic drugs to improve the di...

Full description

Bibliographic Details
Main Authors: Laura De Lellis, Serena Veschi, Nicola Tinari, Zhirajr Mokini, Simone Carradori, Davide Brocco, Rosalba Florio, Antonino Grassadonia, Alessandro Cama
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma
drug repositioning
repurposed drugs
tumor microenvironment
immunomodulation
Online Access:https://www.mdpi.com/2072-6694/13/16/3946

Internet

https://www.mdpi.com/2072-6694/13/16/3946

Similar Items